Mitochondrial Toxicity: Clinical Trials

2 trials for Mitochondrial Toxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1

Follow Mitochondrial Toxicity: new trials by email Literature Review of Mitochondrial Toxicity trials Research Report on Mitochondrial Toxicity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients
Stavudine, Tenofovir - Mitochondrial Toxicity, Metabolic Complications
Phase 4TerminatedUniversity of Witwatersrand, South Africa602008-10-012012-05-18
NRTI-Sparing Pilot Study
lopinavir/ritonavir; nevirapine; Zidovudine; Lamivudine - HIV, Mitochondrial Toxicity
Phase 4CompletedUniversity of British Columbia132002-04-012014-09-26

Narrower conditions

Insulin Resistance (1)

Broader conditions

Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Lamivudine (2)  ·  Lopinavir (1)  ·  Nevirapine (1)  ·  Ritonavir (1)  ·  Stavudine (1)  ·  Tenofovir (1)  ·  Zidovudine (1)  ·  efavirenz (1)

Sponsors

University of British Columbia (1)  ·  University of Witwatersrand, South Africa (1)

Countries

Canada (1)  ·  South Africa (1)

Top investigators

Colin N Menezes, FCP(SA) (1)  ·  Ian Sanne, FCP(SA) (1)  ·  Julio Montaner, MD (1)